The rationale for universal CF NBS became compelling when the disorders’ detrimental impact, earlier than previously apparent, became widely recognized, concurrent with CFTR modulator therapy appearing on the horizon [12,13]. This evidence concerns the gene CFTR and cystic fibrosis.